Union Korea Pharm Co. Ltd. (080720) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Union Korea Pharm Co. Ltd. (080720:KRX), powered by AI.

Current Price
₩2,725
P/E Ratio
-2.1
Market Cap
64.7B
Sector
Healthcare
What is the Union Korea Pharm Co. Ltd. stock price forecast?

Union Korea Pharm Co. Ltd. is currently trading at ₩2,725. View real-time AI analysis on Alpha Lenz.

What is Union Korea Pharm Co. Ltd. insider trading activity?

View the latest insider trading data for Union Korea Pharm Co. Ltd. on Alpha Lenz.

What is Union Korea Pharm Co. Ltd.'s P/E ratio?

Union Korea Pharm Co. Ltd.'s P/E ratio is -2.1.

Union Korea Pharm Co. Ltd.

KRX · 080720
₩2,725+0(+0.00%)Market closedKRX regular session 09:00–15:30 KST
Ask about Union Korea Pharm Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Union Korea Pharm Co. Ltd. trades at a P/E of -2.1 (undervalued) with strong ROE of 420.7%.

Ask for details

Company Overview

Union Korea Pharm Co. Ltd. is a biotechnology and pharmaceutical company based in South Korea. Its primary function is the research, development, production, and sale of pharmaceutical products aimed at addressing a wide range of medical needs. The company specializes in producing both prescription and over-the-counter medications, focusing on therapeutics for conditions such as cardiovascular diseases, antibiotics, and biopharmaceutical innovations. Union Korea Pharm Co. Ltd. influences the healthcare sector significantly through its commitment to advancing medical treatment standards and improving patient outcomes. With a robust focus on innovation and technology, the company plays a crucial role in the pharmaceutical industry, contributing to the growth and development of healthcare solutions in domestic and international markets.

CEO정근호
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees166

Company Statistics

FY 2025

Profile

₩64,693,836,846Market Cap
₩36,378,273,560Revenue
7.91MShares Out
166Employees

Margins

21.53%Gross
-45.25%EBITDA
-47.37%Operating
-76.44%Pre-Tax
-84.72%Net

Valuation

-2.10P/E
-2.82P/B
1.78EV/Sales
-5.04EV/EBITDA
-51.56P/FCF

Growth (CAGR)

-15.96%Rev 3Yr
-6.30%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-51.05%ROA
420.69%ROE
-40.69%ROIC

Financial Health

₩3,124,170,100Cash & Cash Equivalents
₩65,613,327,780Net Debt
-300.14%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Union Korea Pharm Co. Ltd. (ticker: 080720) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 166 employees. Market cap is $64.7B.

The current price is ₩2,725 with a P/E ratio of -2.1x and P/B of -2.82x.

ROE is 420.69% and operating margin is -47.37%. Annual revenue is $36.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Union Korea Pharm Co. Ltd. (080720) Stock Forecast 2026 ₩2,725 — Price, Financials & Analyst Targets | Alpha Lenz